"GLP-1 medications ... have rapidly transformed the management of diabetes and obesity, becoming some of the most requested treatments within employer-sponsored health plans.... [T]he high cost and frequent shortages of these FDA-approved drugs have led employers and patients to explore compounded GLP-1 medications as an alternative. As a pharmacist, [the author aims] to provide clarity on the safety, efficacy, and innovative strategies employers can use when considering compounded GLP-1 therapies."  MORE >>